Hundreds of children in England are being prescribed weight-loss jabs, known as GLP-1 medications, including some younger than 12, according to new figures. The data, obtained by the Guardian through freedom of information requests, reveals that in the financial year 2025-26 there were 419 prescriptions issued to children under 18, with 10 of those for children under 12.
These medications, originally developed for type 2 diabetes, have become popular slimming aids for adults, with brand names like Wegovy and Mounjaro becoming household names. But the rising use among children raises important questions about safety, ethics, and the role of parents in managing their child's weight.
What the figures show
The numbers from the NHS Business Services Authority cover prescriptions dispensed in the community in England. Between April and July this year alone, 341 prescriptions were issued to children, 15 of whom were under 12. However, these figures likely underestimate the true scale because they exclude private prescriptions, hospital settings, and prisons.
One private clinic for children has previously revealed it has more than 200 patients receiving the jabs, suggesting that many more children may be accessing these medications outside the NHS. The data also does not clarify whether the prescriptions were for weight loss or other conditions, such as type 2 diabetes.
Why are children being prescribed weight-loss jabs?
Childhood obesity is a growing concern, and GLP-1 medications offer a new tool for weight management. For some children with severe obesity and related health issues, these drugs may be considered when lifestyle interventions have failed. However, the long-term effects on growing bodies are not fully understood.
Experts caution that these medications should not be seen as a quick fix. They are typically prescribed alongside diet and exercise, and close monitoring is essential. Parents should be aware that GLP-1s can cause side effects such as nausea, vomiting, and diarrhea, and there is limited data on their use in children under 12.
The role of private clinics
The rise of private clinics offering weight-loss jabs to children has raised concerns about regulation and oversight. Unlike NHS prescriptions, private prescriptions are not included in the official figures, making it harder to track how many children are receiving these medications.
Some clinics may be prescribing GLP-1s off-label, meaning they are not specifically approved for children. This practice can be legal but carries additional risks, as the safety and efficacy in children have not been thoroughly studied. Parents should always consult a healthcare professional before considering weight-loss jabs for their child.
What parents should consider
If you are concerned about your child's weight, the first step is to speak with a pediatrician or GP. They can assess your child's overall health and recommend appropriate interventions, which may include dietary changes, increased physical activity, and behavioral support.
Weight-loss jabs should only be considered under medical supervision, and parents should be fully informed about the potential benefits and risks. It's also important to address the psychological aspects of weight management, as children may face stigma or body image issues. The background to this story is set out in Insurance Said No to Your Weight Loss Medication: What Happens Next. A related thread runs through Antibiotic-Resistant Bacteria Threaten Children's Health.
- Always consult a healthcare professional before starting any weight-loss medication for your child.
- Be aware that GLP-1 medications are not approved for children under 12 in most cases.
- Private prescriptions may not be subject to the same oversight as NHS prescriptions.
- Lifestyle changes remain the foundation of weight management for children.
- Monitor for side effects and report any concerns to your doctor.
Comparing GLP-1 medications for children
| Medication | Approved for children? | Common side effects | Notes |
|---|---|---|---|
| Wegovy (semaglutide) | Yes, for ages 12+ | Nausea, diarrhea, vomiting | Approved for obesity in adolescents |
| Mounjaro (tirzepatide) | No (under investigation) | Nausea, constipation, fatigue | Not yet approved for children |
| Ozempic (semaglutide) | No (for diabetes only) | Nausea, abdominal pain | Not approved for weight loss in children |
What to watch next
As the use of weight-loss jabs in children continues to rise, regulators and healthcare providers will need to balance access with safety. Parents should stay informed about new research and guidelines, and advocate for comprehensive care that addresses both physical and mental health. Earlier coverage in Trump's MMR Executive Order Risks Children's Health shows how the argument developed. A closer look at the same subject appears in Trump's MMR Executive Order Endangers Children's Health.
The debate over weight-loss jabs is not limited to children. For a deeper look at the science behind these medications and the hype surrounding them, see our analysis of weight loss jabs: science vs hype on Ozempic breath and hair loss. Meanwhile, in Brazil, Lula's welfare boost and free weight-loss jabs show how governments are grappling with the cost of these treatments. And the fashion industry has not been immune, as Vogue World's weight-loss jab sponsorship sparks ethical concerns.
For parents in England, the key takeaway is to approach weight-loss jabs with caution. While they can be effective for some, they are not a magic solution. A balanced diet, regular exercise, and support from healthcare professionals remain the best approach for children's long-term health. Anyone following the wider picture can start with Child Health Crisis: UK Children at Risk Without Health Visitors. The same theme surfaces in Indigenous Students Retrace Lewis and Clark Journey for Environmental, which takes a different angle.
FAQ
How many children in England are prescribed weight-loss jabs?
In the financial year 2025-26, there were 419 prescriptions for GLP-1 medications issued to children under 18, including 10 for children under 12. These figures exclude private prescriptions, so the actual number may be higher.
Are weight-loss jabs safe for children?
Safety depends on the specific medication and the child's age. Some GLP-1s are approved for adolescents aged 12 and older, but there is limited data for younger children. Side effects can include nausea and vomiting, and long-term effects are unknown.
Can I get weight-loss jabs for my child on the NHS?
In some cases, yes, if a specialist recommends it for severe obesity. However, most prescriptions are for adults, and access for children is limited. Private clinics may offer them, but parents should be cautious and seek medical advice first.
What should I do if I'm worried about my child's weight?
Start by talking to your GP or a pediatrician. They can provide guidance on diet, exercise, and behavioral support, and refer you to a specialist if needed. Avoid self-prescribing or using online sources for weight-loss medications.